Stock Earnings

Question 1

Kintor Pharmaceutical Ltd의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Kintor Pharmaceutical Ltd의 총 자산은 $0이며, 순loss입니다.

Question 2

KNTPF의 주요 재무 비율은 무엇인가요?

Accepted Answer

Kintor Pharmaceutical Ltd의 유동비율은 0이고, 순이익률은 -3,100, 주당 매출은 $0.01입니다.

Question 3

Kintor Pharmaceutical Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Kintor Pharmaceutical Ltd largest revenue segment is Innovative Medicine Products, at a revenue of 5,421,119 in the most earnings release.For geography, China is the primary market for Kintor Pharmaceutical Ltd, at a revenue of 5,421,119.

Question 4

Kintor Pharmaceutical Ltd은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Kintor Pharmaceutical Ltd의 순loss은 $-155입니다.

Question 5

Kintor Pharmaceutical Ltd에 부채가 있나요?

Accepted Answer

no, Kintor Pharmaceutical Ltd의 부채는 0입니다.

Question 6

Kintor Pharmaceutical Ltd의 발행 주식은 몇 주인가요?

Accepted Answer

Kintor Pharmaceutical Ltd의 총 발행 주식은 0주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	10	5	0	0	34	0
Revenue Growth (YoY)	--	--	--	-100%	--	--
Cost of Revenue	17	9	43	0	0	0
Gross Profit	-6	-4	-43	0	34	0
Selling, General & Admin	87	81	86	143	112	83
Research & Development	87	69	929	818	763	325
Operating Expenses	158	150	1,025	969	868	399
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-167	-155	-1,068	-953	-842	-508
Income Tax Expense	0	0	-8	1	0	0
Net Income	-167	-155	-1,060	-954	-842	-508
Net Income Growth	-82%	-85%	11%	13%	66%	119%
Shares Outstanding (Diluted)	434.07	430.72	429.06	377.22	356.39	309.35
Shares Change (YoY)	1%	0%	14%	6%	15%	12%
EPS (Diluted)	-0.38	-0.36	-2.47	-2.53	-2.36	-1.64
EPS Growth	-82%	-85%	-2%	7%	44%	96%
Free Cash Flow	-271	-200	-390	-988	-1,157	-477
Free Cash Flow Per Share	-0.62	-0.46	-0.9	-2.61	-3.24	-1.54
Gross Margin	-60%	-80%	0%	0%	100%	0%
Operating Margin	-1,639.99%	-3,100%	0%	0%	-2,452.94%	0%
Profit Margin	-1,670%	-3,100%	0%	0%	-2,476.47%	0%
Free Cash Flow Margin	-2,710%	-4,000%	0%	0%	-3,402.94%	0%
EBITDA	--	-138	-1,051	-951	-824	-393
EBITDA Margin	--	-2,760%	0%	0%	-2,423.52%	0%
D&A For EBITDA	--	17	18	18	10	6
EBIT	-164	-155	-1,069	-969	-834	-399
EBIT Margin	-1,639.99%	-3,100%	0%	0%	-2,452.94%	0%
Effective Tax Rate	0%	0%	0.74%	-0.1%	0%	0%

Kintor Pharmaceutical Ltd (KNTPF) Price

KNTPF Stock Price Chart

KNTPF Income

Follow-Up Questions